Myriad Genetics Inc (MYGN)
$6.35 -4.80% Close Oct 30, 2026 Live
Myriad Genetics stock today
Myriad Genetics closed at $6.35 on October 30, 2026, down 4.80% on the day. Over the past year it returned -20.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $600 million.
$4.00$6.00$8.00
NovJan 2026MarMayJulSep
| Period | MYGN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +47.3% | -0.9% |
| 3 months | +18.2% | +2.1% |
| Year to date | +3.3% | +11.7% |
| 1 year | -20.1% | +12.4% |
| 3 years | -56.1% | +88.5% |
| 5 years | -79.4% | +76.0% |
Key statistics
- Market value
- $600M
- Price / sales
- 0.7
- 52-week range
- $2.86 to $8.18
- Next report
- Nov 4, 2026
About Myriad Genetics
Myriad Genetics provides genetic testing and precision medicine services.
Sector: Health Care
More on Myriad Genetics
- Financials: revenue, earnings and segmentsRevenue -2% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $322.99 today
No forecast, no recommendation. This page describes Myriad Genetics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.